Literature DB >> 28378125

Humanin inhibits apoptosis in pituitary tumor cells through several signaling pathways including NF-κB activation.

María Florencia Gottardo1,2, Mariela Moreno Ayala2, Jimena Ferraris1,2, Sandra Zárate1,2, Daniel Pisera2, Marianela Candolfi2, Gabriela Jaita1,2, Adriana Seilicovich3,4.   

Abstract

Humanin (HN) and Rattin (HNr), its homologous in the rat, are peptides with cytoprotective action in several cell types such as neurons, lymphocytes and testicular germ cells. Previously, we have shown that HNr is expressed in pituitary cells and that HN inhibited the apoptotic effect of TNF-α in both normal and tumor pituitary cells. The aim of the present study was to identify signaling pathways that mediate the antiapoptotic effect of HN in anterior pituitary cells from ovariectomized rats and in GH3 cells, a somatolactotrope cell line. We assessed the role of STAT3, JNK, Akt and MAPKs as well as proteins of the Bcl-2 family, previously implicated in the antiapoptotic effect of HN. We also evaluated the participation of NF-κB in the antiapoptotic action of HN. STAT3 inhibition reversed the inhibitory effect of HN on TNF-α-induced apoptosis in normal and pituitary tumor cells, indicating that STAT3 signaling pathway mediates the antiapoptotic effect of HN on pituitary cells. Inhibition of NF-κB pathway did not affect action of HN on normal anterior pituitary cells but blocked the cytoprotective effect of HN on TNF-α-induced apoptosis of GH3 cells, suggesting that the NF-κB pathway is involved in HN action in tumor pituitary cells. HN also induced NF-κB-p65 nuclear translocation in these cells. In pituitary tumor cells, JNK and MEK inhibitors also impaired HN cytoprotective action. In addition, HN increased Bcl-2 expression and decreased Bax mitochondrial translocation. Since HN expression in GH3 cells is higher than in normal pituitary cells, we may suggest that through multiple pathways HN could be involved in pituitary tumorigenesis.

Entities:  

Keywords:  Apoptosis; Bcl-2 family proteins; Humanin; NF-κB; Pituitary; STAT3

Year:  2017        PMID: 28378125      PMCID: PMC5704037          DOI: 10.1007/s12079-017-0388-4

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  49 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway.

Authors:  Xingshun Xu; Chu Chang Chua; Jinping Gao; Kao-Wei Chua; Hong Wang; Ronald C Hamdy; Balvin H L Chua
Journal:  Brain Res       Date:  2008-06-16       Impact factor: 3.252

3.  Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.

Authors:  Yuichi Hashimoto; Hiroaki Suzuki; Sadakazu Aiso; Takako Niikura; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Life Sci       Date:  2005-07-06       Impact factor: 5.037

4.  A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats.

Authors:  David C Swinney; Yi-Zheng Xu; Liliana E Scarafia; Ina Lee; Amy Y Mak; Qing-Fen Gan; Chakkodabylu S Ramesha; Mary A Mulkins; Jim Dunn; On-Yee So; Teresa Biegel; Marie Dinh; Pamela Volkel; Jim Barnett; Stacie A Dalrymple; Simon Lee; Martin Huber
Journal:  J Biol Chem       Date:  2002-04-11       Impact factor: 5.157

5.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Authors:  Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline Bromberg; Drew Pardoll; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

6.  Humanin peptide suppresses apoptosis by interfering with Bax activation.

Authors:  Bin Guo; Dayong Zhai; Edelmira Cabezas; Kate Welsh; Shahrzad Nouraini; Arnold C Satterthwait; John C Reed
Journal:  Nature       Date:  2003-05-04       Impact factor: 49.962

7.  The cytoprotective peptide humanin is induced and neutralizes Bax after pro-apoptotic stress in the rat testis.

Authors:  Y Jia; Y-H Lue; R Swerdloff; K-W Lee; L J Cobb; P Cohen; C Wang
Journal:  Andrology       Date:  2013-05-20       Impact factor: 3.842

8.  The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice.

Authors:  Phuong T Hoang; Patricia Park; Laura J Cobb; Valdislava Paharkova-Vatchkova; Michael Hakimi; Pinchas Cohen; Kuk-Wha Lee
Journal:  Metabolism       Date:  2009-10-01       Impact factor: 8.694

9.  NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix.

Authors:  Asha Nair; Manickam Venkatraman; Tessy T Maliekal; Balaraman Nair; Devarajan Karunagaran
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

10.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Authors:  W Wang; J L Abbruzzese; D B Evans; L Larry; K R Cleary; P J Chiao
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  3 in total

1.  Cytoprotective role of humanin in lens epithelial cell oxidative stress‑induced injury.

Authors:  Hao Yang; Yilei Cui; Yelei Tang; Xiajing Tang; Xiaoning Yu; Jiayue Zhou; Qichuan Yin; Xingchao Shentu
Journal:  Mol Med Rep       Date:  2020-06-02       Impact factor: 2.952

Review 2.  Mitochondrial-Derived Peptides in Diabetes and Its Complications.

Authors:  Ying Wu; Liankun Sun; Zhoudao Zhuang; Xiaoqing Hu; Delu Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

3.  Mitochondrial Peptide Humanin Protects Silver Nanoparticles-Induced Neurotoxicity in Human Neuroblastoma Cancer Cells (SH-SY5Y).

Authors:  Sangiliyandi Gurunathan; Muniyandi Jeyaraj; Min-Hee Kang; Jin-Hoi Kim
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.